CD19 and hepatocellular carcinoma: However, there is no significant relationship between the survival and the expression of any canonical lymphocyte subset markers including CD4, CD8, or CD19 in HCC patients (all, P> 0.05, Supplementary Figure 2), based on the mRNA expression from TCGA-LIHC data.